Citadel Advisors »

Processa Pharms shares owned by Citadel Advisors

Quarter-by-quarter ownership of Processa Pharms shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Processa Pharms

Tip: Access up to 7 years of quarterly data

All positions including Processa Pharms held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Processa Pharms by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $106k 315k 0.33
2023-09-30 $42k 166k 0.26
2023-06-30 $141k 283k 0.50
2021-06-30 $83k 10k 8.21
2021-03-31 $143k 13k 10.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Processa Pharms

Citadel Advisors
Vanguard Group
UBS Group
Spinnaker Trust
LLBH Private Wealth Management
Royal Bank of Canada
Two Sigma Investments
Hrt Financial
Wells Fargo & Company

View all funds holding Processa Pharms